Skip to main content
NUTX logo

NUTX · Nutex Health Inc. · Share Buybacks

Track NUTX — free
$212.63 +4.38 (+2.10%) At close · Oct 28 Q1 2026 earnings call transcript
Market Cap
$1.43B
Shares
6.85M
Volume · Oct 28 120.2K Avg daily vol (3M) 155.64K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$25,000,000
as of 2026-03-05 · from 8-K (reviewed)
Remaining Authorization
$19,800,000
as of 2026-06-30
Program Utilization
20.8% $5,200,000 used of $25,000,000
Program Announced Authorized Remaining Runs Through
2026-03-05 $25,000,000 — 2026-09-05 expired
2025-08-14 $25,000,000 — —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it (on today's share basis). Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-06-30 YTD $50,688,000
2025-12-31 $5,000,000

Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.

Key facts CIK 1479681 CUSIP 67079U306 13F (30d) 22 filings 22 filers Visit website Investor relations